These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 16436698

  • 1. Pharmacodynamic activity of amphotericin B deoxycholate is associated with peak plasma concentrations in a neutropenic murine model of invasive pulmonary aspergillosis.
    Wiederhold NP, Tam VH, Chi J, Prince RA, Kontoyiannis DP, Lewis RE.
    Antimicrob Agents Chemother; 2006 Feb; 50(2):469-73. PubMed ID: 16436698
    [Abstract] [Full Text] [Related]

  • 2. Caspofungin: antifungal activity in vitro, pharmacokinetics, and effects on fungal load and animal survival in neutropenic rats with invasive pulmonary aspergillosis.
    van Vianen W, de Marie S, ten Kate MT, Mathot RA, Bakker-Woudenberg IA.
    J Antimicrob Chemother; 2006 Apr; 57(4):732-40. PubMed ID: 16464895
    [Abstract] [Full Text] [Related]

  • 3. Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: evidence of concentration-dependent activity.
    Wiederhold NP, Kontoyiannis DP, Chi J, Prince RA, Tam VH, Lewis RE.
    J Infect Dis; 2004 Oct 15; 190(8):1464-71. PubMed ID: 15378439
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics and pharmacodynamics of amphotericin B deoxycholate, liposomal amphotericin B, and amphotericin B lipid complex in an in vitro model of invasive pulmonary aspergillosis.
    Lestner JM, Howard SJ, Goodwin J, Gregson L, Majithiya J, Walsh TJ, Jensen GM, Hope WW.
    Antimicrob Agents Chemother; 2010 Aug 15; 54(8):3432-41. PubMed ID: 20439615
    [Abstract] [Full Text] [Related]

  • 5. Liposomal nystatin against experimental pulmonary aspergillosis in persistently neutropenic rabbits: efficacy, safety and non-compartmental pharmacokinetics.
    Groll AH, Gonzalez CE, Giri N, Kligys K, Love W, Peter J, Feuerstein E, Bacher J, Piscitelli SC, Walsh TJ.
    J Antimicrob Chemother; 1999 Jan 15; 43(1):95-103. PubMed ID: 10381106
    [Abstract] [Full Text] [Related]

  • 6. Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis.
    Lewis RE, Liao G, Hou J, Chamilos G, Prince RA, Kontoyiannis DP.
    Antimicrob Agents Chemother; 2007 Apr 15; 51(4):1253-8. PubMed ID: 17261624
    [Abstract] [Full Text] [Related]

  • 7. Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis.
    Lewis RE, Prince RA, Chi J, Kontoyiannis DP.
    Antimicrob Agents Chemother; 2002 Oct 15; 46(10):3208-14. PubMed ID: 12234846
    [Abstract] [Full Text] [Related]

  • 8. Antifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbits.
    Petraitis V, Petraitiene R, Groll AH, Bell A, Callender DP, Sein T, Schaufele RL, McMillian CL, Bacher J, Walsh TJ.
    Antimicrob Agents Chemother; 1998 Nov 15; 42(11):2898-905. PubMed ID: 9797223
    [Abstract] [Full Text] [Related]

  • 9. Comparative study on the efficacy of AmBisome and Fungizone in a mouse model of pulmonary aspergillosis.
    Takemoto K, Yamamoto Y, Ueda Y, Sumita Y, Yoshida K, Niki Y.
    J Antimicrob Chemother; 2006 Apr 15; 57(4):724-31. PubMed ID: 16446374
    [Abstract] [Full Text] [Related]

  • 10. Optimization of polyene-azole combination therapy against aspergillosis using an in vitro pharmacokinetic-pharmacodynamic model.
    Siopi M, Siafakas N, Vourli S, Zerva L, Meletiadis J.
    Antimicrob Agents Chemother; 2015 Jul 15; 59(7):3973-83. PubMed ID: 25896699
    [Abstract] [Full Text] [Related]

  • 11. Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model.
    Olson JA, Adler-Moore JP, Schwartz J, Jensen GM, Proffitt RT.
    Antimicrob Agents Chemother; 2006 Jun 15; 50(6):2122-31. PubMed ID: 16723574
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling.
    Groll AH, Mickiene D, Petraitiene R, Petraitis V, Lyman CA, Bacher JS, Piscitelli SC, Walsh TJ.
    Antimicrob Agents Chemother; 2001 Oct 15; 45(10):2845-55. PubMed ID: 11557479
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacodynamics of amphotericin B in a neutropenic-mouse disseminated-candidiasis model.
    Andes D, Stamsted T, Conklin R.
    Antimicrob Agents Chemother; 2001 Mar 15; 45(3):922-6. PubMed ID: 11181381
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy, Biodistribution, and Nephrotoxicity of Experimental Amphotericin B-Deoxycholate Formulations for Pulmonary Aspergillosis.
    López-Sánchez A, Pérez-Cantero A, Torrado-Salmerón C, Martin-Vicente A, García-Herrero V, González-Nicolás MÁ, Lázaro A, Tejedor A, Torrado-Santiago S, García-Rodríguez JJ, Capilla J, Torrado S.
    Antimicrob Agents Chemother; 2018 Jul 15; 62(7):. PubMed ID: 29760126
    [Abstract] [Full Text] [Related]

  • 19. Long-circulating immunoliposomal amphotericin B against invasive pulmonary aspergillosis in mice.
    Otsubo T, Maruyama K, Maesaki S, Miyazaki Y, Tanaka E, Takizawa T, Moribe K, Tomono K, Tashiro T, Kohno S.
    Antimicrob Agents Chemother; 1998 Jan 15; 42(1):40-4. PubMed ID: 9449258
    [Abstract] [Full Text] [Related]

  • 20. In vivo resistance of a laboratory-selected Aspergillus fumigatus isolate to amphotericin B.
    Manavathu EK, Cutright JL, Chandrasekar PH.
    Antimicrob Agents Chemother; 2005 Jan 15; 49(1):428-30. PubMed ID: 15616327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.